One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1136/jmg-2023-109185
Copy DOI Journal: Journal of Medical Genetics |  Publication Date: Jul 14, 2023 |
 Citations: 1 |  License type: CC BY 4.0 |
Affiliation: Tel Aviv University, German Cancer Research Center, Heidelberg University, University of Sheffield, University of Cambridge, Cedars-Sinai Medical Center, University Medical Center Hamburg-Eppendorf, Universität Hamburg, Karolinska Institutet, Karolinska University Hospital, University Hospital Ulm, Hadassah Medical Center, Hebrew University of Jerusalem, University of Southampton, Oslo University Hospital, University of Oslo, University Hospital of Heraklion, Servicio Gallego de Salud, Stockholm South General Hospital, Manchester University NHS Foundation Trust, St Mary's Hospital, Manchester Academic Health Science Centre, University of Manchester, University of Western Australia, University of Melbourne, Hospital Clínico San Carlos, Royal Victoria Regional Health Centre, McGill University, Comprehensive Cancer Center Erlangen, National Cancer Institute, National Institutes of Health, Columbia University, Institute of Cancer Research, Breast Cancer Now, University Health Network, University of Toronto, Stanford University, University of Eastern Finland, Kuopio University Hospital, National Institute of Environmental Health Sciences, Carmel Medical Center, Lund University, Leiden University Medical Center, Oncode Institute, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Harvard University, Brigham and Women's Hospital, University Hospital of Larissa, Memorial Sloan Kettering Cancer Center, National Center for Tumor Diseases, Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute, University of Tübingen, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Gentofte Hospital, Copenhagen University Hospital, Medical School Hamburg, Hannover Medical School, KU Leuven, International Agency For Research On Cancer, Federico II University Hospital, Ufa Institute of Chemistry, Bashkir State University, Pomeranian Medical University, University Cancer Center Hamburg, University of Hawaii System, Cancer Center of Hawaii, University of Hawaiʻi at Mānoa, FIRC Institute of Molecular Oncology, Mayo Clinic, Vanderbilt University, Clalit Health Services, Rabin Medical Center, American Cancer Society, City of Hope, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, German Breast group, University of North Carolina at Chapel Hill, Huntsman Cancer Institute, University of Utah, Centre for Research in Epidemiology and Population Health, Versailles Saint-Quentin-en-Yvelines University, Inserm, Cancer Council Victoria, Monash University, Monash Health, Erasmus MC, University College London, MRC Clinical Trials Unit, VIB-KU Leuven Center for Cancer Biology, The Ohio State University, N.N. Alexandrov National Cancer Centre, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Sydney, Westmead Institute for Medical Research, University of Kansas Medical Center, Curtin University, Université Laval, BC Cancer Agency, University of British Columbia, University of California, Irvine, Cyprus Institute of Neurology and Genetics, Fox Chase Cancer Center, Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago, Complejo Hospitalario Universitario de SantiagoBackgroundPolygenic risk score (PRS), calculated based on genome-wide association studies (GWASs), can improve breast cancer (BC) risk assessment. To date, most BC GWASs have been performed in individuals of European...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
